Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Baran AM"'
Autor:
Sven Schinner, C. Papewalis, Matthias Schott, Werner A. Scherbaum, Baran Am, Holger S. Willenberg, M. Wuttke
Publikováno v:
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 41(10)
Activation of the phosphatidylinositol-3-kinase (PI3K) signaling cascade is increasingly recognized as a common feature of thyroid follicular neoplasms. Among the PI3K downstream effectors, the main kinase, directly responsible for the increased cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ae4acf7a14aecaadc101cc0fe0384f8
https://pubmed.ncbi.nlm.nih.gov/19513966
https://pubmed.ncbi.nlm.nih.gov/19513966
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Niraula S; Vassar Brothers Medical Center, Nuvance Health, Poughkeepsie, NY., Gouli S; Rochester General Hospital, Rochester, NY., Baran AM; University of Rochester Medical Center, Rochester, NY., O'Regan R; University of Rochester Medical Center, Rochester, NY., Tyburski H; University of Rochester Medical Center, Rochester, NY., Zhang H; University of Rochester Medical Center, Rochester, NY., Hardy S; University of Washington School of Medicine, Fred Hutchinson Cancer Center, Seattle, Washington., Mohile N; University of Rochester Medical Center, Rochester, NY., Anders CK; Duke Cancer Institute, Durham, NC., Dhakal A; University of Rochester Medical Center, Rochester, NY. Electronic address: ajay_dhakal@urmc.rochester.edu.
Publikováno v:
Clinical breast cancer [Clin Breast Cancer] 2024 Oct 05. Date of Electronic Publication: 2024 Oct 05.
Autor:
Baran AM; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, 265 Crittenden Blvd., Box 630, Rochester, NY 14642, USA., Patil AH; Lieber Institute for Brain Development, Johns Hopkins University, 855 North Wolfe St. Suite 300, Baltimore, MD 21205, USA., Aparicio-Puerta E; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, 265 Crittenden Blvd., Box 630, Rochester, NY 14642, USA., Halushka MK; Department of Pathology, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195, USA., McCall MN; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, 265 Crittenden Blvd., Box 630, Rochester, NY 14642, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Jul 18. Date of Electronic Publication: 2024 Jul 18.
Autor:
Hill BT; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Ma S; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL., Zent CS; Wilmot Cancer Institute, University of Rochester, Rochester, NY., Baran AM; Wilmot Cancer Institute, University of Rochester, Rochester, NY., Wallace DS; Wilmot Cancer Institute, University of Rochester, Rochester, NY., Advani A; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Winter A; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Winter J; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL., Gordan L; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL., Karmali R; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL., Liesveld JL; Wilmot Cancer Institute, University of Rochester, Rochester, NY., Mulford DA; Wilmot Cancer Institute, University of Rochester, Rochester, NY., Rowland C; TG Therapeutics, Morrisville, NC., Bui A; TG Therapeutics, Morrisville, NC., Sportelli P; TG Therapeutics, Morrisville, NC., Miskin HP; TG Therapeutics, Morrisville, NC., Weiss MS; TG Therapeutics, Morrisville, NC., Friedberg JW; Wilmot Cancer Institute, University of Rochester, Rochester, NY., Barr PM; Wilmot Cancer Institute, University of Rochester, Rochester, NY.
Publikováno v:
Blood advances [Blood Adv] 2024 Jan 23; Vol. 8 (2), pp. 378-387.
Autor:
Wallace DS; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Rowland C; TG Therapeutics, Inc, New York, NY, USA., Hill BT; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Baran AM; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA., Casulo C; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Reagan PM; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Winter A; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Karmali R; Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA., Winter JN; Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA., Gordon LI; Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA., Bui A; TG Therapeutics, Inc, New York, NY, USA., Sportelli P; TG Therapeutics, Inc, New York, NY, USA., Miskin HP; TG Therapeutics, Inc, New York, NY, USA., Weiss MS; TG Therapeutics, Inc, New York, NY, USA., Friedberg JW; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Ma S; Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA., Barr PM; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Sep; Vol. 64 (9), pp. 1579-1582. Date of Electronic Publication: 2023 Jun 21.
Autor:
Wallace DS; Wilmot Cancer Institute and Department of Medicine, University of Rochester, Rochester, NY., Zent CS; Wilmot Cancer Institute and Department of Medicine, University of Rochester, Rochester, NY., Baran AM; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY., Reagan PM; Wilmot Cancer Institute and Department of Medicine, University of Rochester, Rochester, NY., Casulo C; Wilmot Cancer Institute and Department of Medicine, University of Rochester, Rochester, NY., Rice G; Wilmot Cancer Institute and Department of Medicine, University of Rochester, Rochester, NY., Friedberg JW; Wilmot Cancer Institute and Department of Medicine, University of Rochester, Rochester, NY., Barr PM; Wilmot Cancer Institute and Department of Medicine, University of Rochester, Rochester, NY.
Publikováno v:
Blood advances [Blood Adv] 2023 Jun 13; Vol. 7 (11), pp. 2496-2503.
Autor:
Moore JE; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, United States; Department of Pharmacy, University of Rochester Medical Center, Rochester, NY, United States., Bloom PC; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, United States., Chu CC; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, United States; Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, United States., Bruno JE; Center for Vaccine Biology & Immunology, University of Rochester Medical Center, Rochester, NY, United States; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, United States., Herne CA; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, United States., Baran AM; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, United States., Quataert SA; Center for Vaccine Biology & Immunology, University of Rochester Medical Center, Rochester, NY, United States; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, United States., Mosmann TR; Center for Vaccine Biology & Immunology, University of Rochester Medical Center, Rochester, NY, United States; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, United States., Taylor RP; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, United States., Wallace DS; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, United States; Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, United States., Elliott MR; Center for Cell Clearance and the Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, United States., Barr PM; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, United States; Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, United States., Zent CS; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, United States; Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, United States. Electronic address: clive_zent@urmc.rochester.edu.
Publikováno v:
Leukemia research [Leuk Res] 2023 Jun; Vol. 129, pp. 107072. Date of Electronic Publication: 2023 Mar 29.
Autor:
Archibald WJ; James P Wilmot Cancer Institute, Division of Hematology and Medical Oncology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. Electronic address: william_archibald@urmc.rochester.edu., Baran AM; James P Wilmot Cancer Institute, Division of Hematology and Medical Oncology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., Williams AM; James P Wilmot Cancer Institute, Division of Hematology and Medical Oncology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., Salloum RM; Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., Richard Burack W; Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., Evans AG; Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., Syposs CR; Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., Zent CS; James P Wilmot Cancer Institute, Division of Hematology and Medical Oncology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
Publikováno v:
Leukemia research [Leuk Res] 2023 May; Vol. 128, pp. 107053. Date of Electronic Publication: 2023 Mar 02.
Autor:
Peterson DR; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, USA., Baran AM; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, USA., Bhattacharya S; Division of Neonatology and Pediatric Molecular and Personalized Medicine Program, Department of Pediatrics, University of Rochester, Rochester, New York, USA., Branche AR; Division of Infectious Diseases, Department of Medicine, University of Rochester, Rochester, New York, USA., Croft DP; Division of Pulmonary and Critical Care, Department of Medicine, University of Rochester, Rochester, New York, USA., Corbett AM; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, USA., Walsh EE; Division of Infectious Diseases, Department of Medicine, University of Rochester, Rochester, New York, USA.; Department of Medicine, Rochester General Hospital, Rochester, New York, USA., Falsey AR; Division of Infectious Diseases, Department of Medicine, University of Rochester, Rochester, New York, USA.; Department of Medicine, Rochester General Hospital, Rochester, New York, USA., Mariani TJ; Division of Neonatology and Pediatric Molecular and Personalized Medicine Program, Department of Pediatrics, University of Rochester, Rochester, New York, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2023 Feb 01; Vol. 227 (3), pp. 322-331.